LAMEA Ocular Trauma Devices Market Size, Share & Industry Trends Analysis Report By End-Use, By Type (Implants, Instruments, and Disposables), By Indication (Blunt Trauma, Chemical Trauma, and Sharp Trauma), By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Ocular Trauma Devices Market should witness market growth of 8.8% CAGR during the forecast period (2022-2028).

Serious eye trauma necessitates pricy hospitalization, specialized care, and frequently extended follow-up and vision rehabilitation. Forthe medical system and the patient, this comes at a huge financial cost. Therefore, it is crucial to design effective prevention and management plans as well as a deeper understanding of the regional patterns of ocular injuries.

For badly injured eyes, surgical procedures are typically required. In comparison to eyes with a limbal path, eyes with IOFBs isolated from the entryway wound route can haveimproved visual outcomes. Especially in comparison to the pars plana path, the entrance wound path also enables bigger intraocular foreign body removal.

Ocular trauma shows a seasonal pattern, increasing in the autumn and summer and commencing around the start of the school year. As traumatic occurrences are more likely to necessitate surgical intervention, more cases turn up in July that needs effective management of ocular injuries to prevent blindness.

Blindness and monocular vision impairment are frequently caused by ocular trauma in this region. Between 34.3% and 76.6% of people in Ghana and Ethiopia are monocularly blind, according to several studies. Though those who have monocular blindness are not regarded as being legally blind, these wounds are important because they have an impact on the binocular visual field, the cosmoses, stereopsis, and on the sufferers' future professional lives.

The Brazil market dominated the LAMEA Ocular Trauma Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $76.9 Million by 2028. The Argentina market is experiencing a CAGR of 9.4% during (2022-2028). Additionally, The UAE market would display a CAGR of 8.5% during (2022-2028).

Based on End-Use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on Type, the market is segmented into Implants, Instruments, and Disposables. Based on Indication, the market is segmented into Blunt Trauma, Chemical Trauma, and Sharp Trauma. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Glaukos Corporation, Alcon, Inc., EssilorLuxottica SA (Essilor Instruments USA), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Carl Zeiss AG, Topcon Corporation, CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Hoya Corporation.

Scope of the Study

By End-Use

• Hospitals
• Ophthalmic Clinics
• Others

By Type

• Implants
• Instruments
• Disposables

By Indication

• Blunt Trauma
• Chemical Trauma
• Sharp Trauma

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
• Glaukos Corporation
• Alcon, Inc.
• EssilorLuxottica SA (Essilor Instruments USA)
• Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
• Carl Zeiss AG
• Topcon Corporation
• CooperVision, Inc. (THE COOPER COMPANIES, INC.)
• Hoya Corporation

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free